REGN
Regeneron Pharmaceuticals Inc
NASDAQ
896.82
USD
0.32%
+2.83
OPEN
914.99
PREV CLOSE
893.99
DAY RANGE
920.73 - 891.46
VOLUME
501.4K
AVG. VOLUME
500.1K
52 WEEK RANGE
998.33 - 684.81
Buy REGN stocks now with Interactive Brokers – the most advanced investment platform
Loading
Valuations metrics
Market capitalization
98.5B
Enterprise value
88.8B
Trailing pe
25.794685
Forward pe
18.886072
Peg ratio
18.886072
Price to sales ttm
7.51139
Price to book mrq
3.7020977
Enterprise to revenue
6.769
Enterprise to ebitda
19.077
Financials
Fiscal year ends
2023-12-31
Most recent quarter
2023-12-31
Profit margin
0.30141002
Operating margin
0.29202
Return on assets ttm
0.08494
Return on equity ttm
0.16258
Income statement
Revenue ttm
13.1B
Revenue per share ttm
122.935
Quarterly revenue growth
0.006
Gross profit ttm
11.3B
Ebitda
5.1B
Net income to common ttm
4B
Diluted eps ttm
34.8
Quarterly earnings growth yoy
-0.031
Balance sheet
Total cash mrq
10.8B
Total cash per share mrq
100.918
Total debt mrq
2.8B
Total debt to equity mrq
10.744
Current ratio mrq
5.69
Book value per share mrq
242.472
Cash flow
Operating cash flow ttm
4.6B
Levered free cash flow ttm
2.8B
Stock statistics
Shares outstanding
107.9M
Float shares
102.8M
Avg 10 volume
451.7K
Avg 90 volume
435.8K
Shares short
1.4M
Short ratio
3.19
Short percent of shares outstanding
0.0154
Percent held by insiders
0.02582
Percent held by institutions
0.8928
Stock price summary
Fifty two week low
684.81
Fifty two week high
998.33
Fifty two week change
10.715
Beta
0.141
Day 50 ma
954.5046
Day 200 ma
857.4452
